| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $40,610,930 ) |
| | 2024 | 2024 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | UM1AI109565 | Immune Tolerance Network | 001 | 11 | NIH | 2/6/2024 | $26,502,056 |
| | 2024 | 2024 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | F32HL172506 | Requirement of HIF2a signaling in Th2 cell differentiation and allergic asthma | 001 | 1 | NIH | 1/10/2024 | -$71,792 |
| | 2024 | 2024 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | F32HL172506 | Requirement of HIF2a signaling in Th2 cell differentiation and allergic asthma | 000 | 1 | NIH | 12/29/2023 | $71,792 |
| | 2024 | 2024 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | R21AI176366 | Modulation of pathogenic T cells in EAE | 000 | 1 | NIH | 11/13/2023 | $233,955 |
| | 2024 | 2024 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | R01AI181275 | Regulatory T cells maintain immune homeostasis through translation control | 000 | 1 | NIH | 12/13/2023 | $801,433 |
| | 2024 | 2024 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | R01AI181275 | Regulatory T cells maintain immune homeostasis through translation control | 001 | 1 | NIH | 12/15/2023 | $0 |
| | 2024 | 2024 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | R21AI171921 | Regulation of TLR signaling in anti-commensal B cell responses and mucosal inflammation | 000 | 2 | NIH | 3/21/2024 | $216,625 |
| | 2024 | 2024 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | R21AI178426 | Foxp3 isoforms and IgE-mediated UVB-induced skin inflammation expression | 000 | 2 | NIH | 4/15/2024 | $216,625 |
| | 2024 | 2024 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | R01DK132593 | Harnessing engineered T regulatory cells to promote beta cell health in T1D | 000 | 3 | NIH | 2/21/2024 | $975,699 |
| | 2024 | 2024 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | U19AI167891 | Systems Immunology profiling of respiratory viral infections in vulnerable populations | 002 | 3 | NIH | 4/23/2024 | $228,383 |
| | 2024 | 2024 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | U19AI167891 | Systems Immunology profiling of respiratory viral infections in vulnerable populations | 001 | 3 | NIH | 2/26/2024 | $2,055,477 |
| | 2024 | 2024 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | R01AI158624 | Commensal-specific T cell function in skin wound repair | 000 | 4 | NIH | 12/29/2023 | $528,587 |
| | 2024 | 2024 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | R01AI141952 | Defining mechanisms of CD8 T cell exhaustion in T1D | 000 | 5 | NIH | 3/27/2024 | $578,210 |
| | 2024 | 2024 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | R01AI150178 | BCAP regulation of TLR7/9 signaling in Lupus | 000 | 5 | NIH | 11/14/2023 | $544,379 |
| | 2024 | 2024 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | R21AI176365 | DCs as clinical targets of anti-integrin therapy in IBD | 000 | 1 | NIH | 11/30/2023 | $233,955 |
| | 2024 | 2024 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | UM1AI109565 | Immune Tolerance Network | 000 | 10 | NIH | 2/1/2024 | $7,500,000 |
| | 2024 | 2023 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | UM1AI109565 | Immune Tolerance Network | 002 | 10 | NIH | 4/2/2024 | $0 |
| | 2024 | 2023 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | U19AI167891 | Systems Immunology profiling of respiratory viral infections in vulnerable populations | 000 | 2 | NIH | 2/22/2024 | $0 |
| | 2024 | 2022 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | F32AI154787 | Regulation of germinal centers by thymic stromal lymphopoietin in mice and humans | 000 | 3 | NIH | 4/24/2024 | -$4,184 |
| | 2024 | 2022 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | R21AI157440 | Control of CD8+ T cell migration and activation by Flightless-1 | 000 | 2 | NIH | 1/23/2024 | -$44 |
| | 2024 | 2021 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | R21AI150253 | Mechanisms of suppression of effector T cells in EAE | 000 | 2 | NIH | 11/15/2023 | -$226 |
| | 2024 | 2021 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | U19AI135817 | Allergen T cell epitopes and phenotypes in peanut allergy and immunotherapy | 000 | 4 | NIH | 4/29/2024 | $0 |
| | 2024 | 2021 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | R01AI127726 | Regulation of cutaneous immunity and tissue-repair by a specialized population of CD4+ T cells | 000 | 5 | NIH | 10/23/2023 | $0 |
| | 2024 | 2021 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | R01AI129548 | Regulation of pathogenic T cells in EAE | 000 | 5 | NIH | 10/24/2023 | $0 |
| | 2024 | 2021 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | R03TR003701 | Illuminating a novel role of understudied DYRKs in anti-inflammatory T cell differentiation | 000 | 1 | NIH | 1/22/2024 | $0 |
| | 2024 | 2020 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | R01AI132774 | Mechanisms of IL-6 mediated T cell pathogenesis in autoimmunity | 000 | 4 | NIH | 3/7/2024 | $0 |
| | 2024 | 2020 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | R01AI132774 | Mechanisms of IL-6 mediated T cell pathogenesis in autoimmunity | 001 | 4 | NIH | 3/7/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $54,817,885 ) (Continued on the next page) |
| | 2023 | 2023 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | R01AI158624 | Commensal-specific T cell function in skin wound repair | 000 | 3 | NIH | 2/1/2023 | $587,319 |
| | 2023 | 2023 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | DP2AI183504 | Investigating Genetic and Epigenetic Control of T Cell Function in Autoimmunity | 000 | 1 | NIH | 9/8/2023 | $1,559,700 |
| | 2023 | 2023 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | R21AI168951 | Prioritizing autoimmune-associated genetic variants that alter regulatory element activity in B cells | 000 | 2 | NIH | 3/14/2023 | $216,625 |
| | 2023 | 2023 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | U19AI167891 | Systems Immunology profiling of respiratory viral infections in vulnerable populations | 002 | 2 | NIH | 5/22/2023 | $0 |
| | 2023 | 2023 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | U19AI167891 | Systems Immunology profiling of respiratory viral infections in vulnerable populations | 001 | 2 | NIH | 2/3/2023 | $2,283,860 |
| | 2023 | 2023 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | U19AI167891 | Systems Immunology profiling of respiratory viral infections in vulnerable populations | 003 | 2 | NIH | 7/13/2023 | $0 |
| | 2023 | 2023 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | R21AI164332 | Characterization of E. coli-specific T cells in Crohn's disease | 000 | 2 | NIH | 1/31/2023 | $216,625 |
| | 2023 | 2023 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | R01AI169893 | Reprogramming of tissue structural cells by cutaneous CD4+ T cells | 000 | 1 | NIH | 4/19/2023 | $645,651 |
| | 2023 | 2023 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | R21AI171921 | Regulation of TLR signaling in anti-commensal B cell responses and mucosal inflammation | 000 | 1 | NIH | 4/19/2023 | $259,950 |
| | 2023 | 2023 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | U01AI176320 | T cells promoting transitions toward autoimmunity | 000 | 1 | NIH | 8/18/2023 | $1,316,264 |
| | 2023 | 2023 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | R01DK132593 | Harnessing engineered T regulatory cells to promote beta cell health in T1D | 000 | 2 | NIH | 1/26/2023 | $975,699 |
| | 2023 | 2023 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | U01DK127404 | Type 1 Diabetes in Acute Pancreatitis Consortium, Pacific Northwest Clinical Center: Immune Pathogenesis of Post-Pancreatitis T1D | 001 | 4 | NIH | 8/2/2023 | $215,625 |
| | 2023 | 2023 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | R01HL149676 | Immune Checkpoints in Acute Respiratory Distress Syndrome (IC-ARDS) | 000 | 4 | NIH | 6/17/2023 | $542,628 |
| | 2023 | 2023 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | R01AI141952 | Defining mechanisms of CD8 T cell exhaustion in T1D | 000 | 4 | NIH | 2/28/2023 | $574,380 |
| | 2023 | 2023 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | R01CA231226 | Anti-tumor and autoimmunity signatures in Down syndrome | 002 | 5 | NIH | 9/18/2023 | $648,776 |
| | 2023 | 2023 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | R01CA231226 | Anti-tumor and autoimmunity signatures in Down syndrome | 001 | 5 | NIH | 8/18/2023 | $845,601 |
| | 2023 | 2023 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | UM1AI109565 | Immune Tolerance Network | 008 | 10 | NIH | 8/30/2023 | $214,157 |
| | 2023 | 2023 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | UM1AI109565 | Immune Tolerance Network | 008 | 10 | NIH | 8/30/2023 | $2,180,000 |
| | 2023 | 2023 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | UM1AI109565 | Immune Tolerance Network | 008 | 10 | NIH | 8/30/2023 | $3,150,000 |
| | 2023 | 2023 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | UM1AI109565 | Immune Tolerance Network | 007 | 10 | NIH | 5/25/2023 | $2,034,972 |
| | 2023 | 2023 | BENAROYA RESEARCH INSTITUTE AT VIRGINIA MASON | 1201 9TH AVE | SEATTLE | WA | 98101-2795 | KING | USA | UM1AI109565 | Immune Tolerance Network | 006 | 10 | NIH | 5/17/2023 | $0 |
|
